Chen et al. identified MLYCD as a regulator of ferroptosis sensitivity in clear cell renal cell carcinoma (ccRCC) and identified a novel therapeutic target for ccRCC [144]. The gene discussed is MLYCD; the disease is nonpapillary renal cell carcinoma.